Longevity Acquisition Corporation Right
LOACR
LOACR was delisted on the 19th of March, 2021.
8 hedge funds and large institutions have $460K invested in Longevity Acquisition Corporation Right in 2019 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 4 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 8 → 8 (0)
21% less capital invested
Capital invested by funds: $579K → $460K (-$119K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$21.7K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$7.11K |
| 3 |
BI
Bulldog Investors
Saddle Brook,
New Jersey
|
-$1.78K |
| 4 |
Walleye Trading
New York
|
-$954 |
LOACR Hedge Fund Activity: Q3 2019 in Review
8 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Longevity Acquisition Corporation Right (LOACR) for Q3 2019, worth a combined $460K — down 21% from $579K a quarter earlier.
Fund positioning in LOACR was balanced in Q3 2019: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 4 trimmed.
The largest seller was Oxford Asset Management, cutting an estimated $21.7K.
- 8 institutional investors held Longevity Acquisition Corporation Right (LOACR) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $460K of Longevity Acquisition Corporation Right stock for Q3 2019, down 21% quarter-over-quarter.
- 0 funds opened new Longevity Acquisition Corporation Right positions in Q3 2019 and 0 closed out.
- The largest Longevity Acquisition Corporation Right seller in Q3 2019 was Oxford Asset Management, an estimated $21.7K sold.
Based on aggregated 13F filings for Q3 2019.